Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 5 Unknown 2 Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 44 Squamous Cell Carcinoma of Head and Neck 19 Breast Neoplasms 18 Lung Neoplasms 17 Colorectal Neoplasms 15 Neoplasms 12 Neoplasm Metastasis 12 Head and Neck Neoplasms 12 Ovarian Neoplasms 11 Small Cell Lung Carcinoma 9 Recurrence 9 Sarcoma 8 Pancreatic Neoplasms 8 Prostatic Neoplasms 7 Advanced Solid Tumors 7 Urinary Bladder Neoplasms 6 Triple Negative Breast Neoplasms 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Uterine Cervical Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Biliary Tract Neoplasms 5 Mesothelioma, Malignant 4 Lymphoma, Follicular 4 Lymphoma 4 Fallopian Tube Neoplasms 4 Esophageal Neoplasms 4 Cholangiocarcinoma 4

Interventions

pembrolizumab 25 Gemcitabine 21 Nivolumab 17 Cisplatin 17 atezolizumab 14 Carboplatin 11 avelumab 9 vinflunine 7 Ipilimumab 7 Paclitaxel 6 Docetaxel 5 enfortumab vedotin 4 cabazitaxel 4 Pemetrexed 4 Mitomycin 4 cabozantinib 3 Taxes 3 Rogaratinib 3 Magnetic Resonance Spectroscopy 3 Injections 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 sacituzumab govitecan 2 pemigatinib 2 niraparib 2 lenvatinib 2 bempegaldesleukin 2 apatorsen 2 XRP6258 2 Vitamin D 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Transitional Cell × durvalumab × Clear all

NCT03871036 2025-03-06

ICRA

The Netherlands Cancer Institute

Phase 1/2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡